AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2023
May 19, 2023
30016_dirs_2023-05-19_bbc8565a-2ba4-4b5a-9813-252b7f2a5939.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2023-05-17
Reporting Person: Vandebroek Sophie V. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-17 | Non-Qualified Stock Option (right-to-buy) | $487.12 | A | 645 | Acquired | 2033-05-16 | Common Stock (645.0) | Direct |
| 2023-05-17 | Restricted Stock Unit | $ | A | 257 | Acquired | Common Stock (257.0) | Direct |
Footnotes
F1: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event is earlier.
F2: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event is earlier.